Abiraterone Mylan Europäische Union - Deutsch - EMA (European Medicines Agency)

abiraterone mylan

mylan ireland limited - abirateronacetat - prostata-neoplasmen - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Abiraterone Krka Europäische Union - Deutsch - EMA (European Medicines Agency)

abiraterone krka

krka, d.d., novo mesto - abirateronacetat - prostata-neoplasmen - endokrine therapie - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Abirateron EG 250 mg Filmtablette Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

abirateron eg 250 mg filmtablette

eurogenerics afgekort "e.g." - abiraterone acetat - filmtablette - 250 mg - abiraterone acetat 250 mg - abiraterone

Abirateron EG 500 mg Filmtablette Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

abirateron eg 500 mg filmtablette

eurogenerics afgekort "e.g." - abiraterone acetat - filmtablette - 500 mg - abiraterone acetat 500 mg - abiraterone

Abirateron Fresenius Kabi 500 mg Filmtablette Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

abirateron fresenius kabi 500 mg filmtablette

fresenius kabi - abiraterone acetat - filmtablette - 500 mg - abiraterone acetat 500 mg - abiraterone

Abirateron Fresenius Kabi 250 mg Tablette Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

abirateron fresenius kabi 250 mg tablette

fresenius kabi - abiraterone acetat - tablette - 250 mg - abiraterone acetat 250 mg - abiraterone

Bixodalan 250 mg Filmtablette Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bixodalan 250 mg filmtablette

sandoz - abiraterone acetat - filmtablette - 250 mg - abiraterone acetat 250 mg - abiraterone

Bixodalan 500 mg Filmtablette Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bixodalan 500 mg filmtablette

sandoz - abiraterone acetat - filmtablette - 500 mg - abiraterone acetat 500 mg - abiraterone

Bixodalan 1000 mg Filmtablette Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bixodalan 1000 mg filmtablette

sandoz - abiraterone acetat - filmtablette - 1000 mg - abiraterone acetat 1000 mg - abiraterone

Abiraterone Accord Europäische Union - Deutsch - EMA (European Medicines Agency)

abiraterone accord

accord healthcare s.l.u. - abirateronacetat - prostata-neoplasmen - endokrine therapie - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.